At poll rally, Yogi calls Indian Army 'Modi ji ki sena'

Agencies
April 1, 2019

Ghaziabad, Apr 1: Uttar Pradesh Chief Minister Yogi Adityanath described the Indian Army as "Modi ji ki sena" (Prime Minister Narendra Modi's Army) during an election campaign for the BJP here.

Hitting out at Opposition parties over a host of governance issues Sunday, Adityanath said what was "impossible" for the Congress, Samajwadi Party and the Bahujan Samaj Party is possible under the BJP rule.

"Congress ke log aatankwadiyon ko biryani khilate the aur Modi ji ki sena aatankwadiyon ko goli aur gola deti hai (Congress people would feed biryani to terrorists, while Modi's army gives them bullet or bomb). This is the difference. The Congress people use 'ji' in Masood Azhar's name to encourage terrorism," he said.

"Under Prime Minister Modi's leadership, terror camps are being destroyed which is breaking the back of terrorists and Pakistan. This is the work being done by the BJP government and this is the difference," the Uttar Pradesh chief minister added.

"What was namumkin (impossible) for the Congress is mumkin (possible) for PM Modi. Because when Modi is there, the impossible becomes possible," he said.

Campaigning for sitting MP and Union minister V K Singh, Adityanath earlier listed out the achievements brought in the region under five years of Modi rule in the Centre and two years of his in the state.

He also said the situation of safety in western Uttar Pradesh has improved and nobody can misbehave with women and girls, while criminals are either behind the bars or dead.

Comments

kumar
 - 
Tuesday, 2 Apr 2019

I think this crature Yogi is becoming mad day by day and am sure that soon he will be 100 percent mad and will be seen running in the streets naked.  He is giving illogic and communal statemetns.  EC should take note of his speech and ban him from giving any speech in public.   He is spread hate among different communities which may lead to riot causing death and loss to public plus govt properties. 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 2,2020

New Delhi, Jun 2: India on Tuesday reported 8,171 more COVID-19 cases and 204 deaths in the last 24 hours as the country's virus count inches closer to two lakh, according to the Union Ministry of Health and Family Welfare.

The total number of cases in the country now stands at 1,98,706 including 97,581 active cases, 95,527 cured/discharged/migrated and 5,598 deaths.

Cases in Maharashtra have crossed 70,000 including over 30,000 recovered while Tamil Nadu's COVID-19 tally jumped to 23,495.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 10,2020

New Delhi, Feb 10: Former Jammu and Kashmir chief minister Omar Abdullah's sister on Monday moved the Supreme Court to challenge his detention under the Public Safety Act.

Senior advocate Kapil Sibal, appearing for the petitioner, mentioned the matter for urgent listing before a bench headed by Justice N V Ramana.

Sibal told the bench that they have filed a habeas corpus petition challenging the detention of Abdullah under the PSA and the matter should be heard this week.

The bench agreed for urgent listing of the matter.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.